Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
Other Current Assets
Iterum Therapeutics PLC
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
Other Current Assets
$1.6m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
Perrigo Company PLC
NYSE:PRGO
|
Other Current Assets
$220.9m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Other Current Assets
$357m
|
CAGR 3-Years
20%
|
CAGR 5-Years
31%
|
CAGR 10-Years
17%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Other Current Assets
$11.3m
|
CAGR 3-Years
30%
|
CAGR 5-Years
26%
|
CAGR 10-Years
19%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Other Current Assets
$2.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Other Current Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Iterum Therapeutics PLC's Other Current Assets?
Other Current Assets
1.6m
USD
Based on the financial report for Dec 31, 2023, Iterum Therapeutics PLC's Other Current Assets amounts to 1.6m USD.
What is Iterum Therapeutics PLC's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
-26%
Over the last year, the Other Current Assets growth was 36%. The average annual Other Current Assets growth rates for Iterum Therapeutics PLC have been -29% over the past three years , -26% over the past five years .